Guided by patient organizations from 13 countries with leadership and support from Global Parents for Eczema Research

The Global Patient Initiative to Improve Eczema Care (GPIIEC) is a first: A global partnership of 15 patient advocacy organizations located in 13 countries and 5 continents.

Steering Committee

Global Parents for Eczema Research Team

  • Korey. Capozza

    Executive Director, GPER

    USA

  • Alan Schwartz

    Methodology Consultant

    University of Illinois, Chicago, USA

  • Michelle Tu

    Project Manager, GPER

    USA

  • Kara Orevillo

    Research Associate, GPER

    USA

  • Freya Moxham

    Research Associate, GPER

    UK

  • Jessica Lang

    Research Volunteer, GPER

    USA

“Working together, we’ve learned that issues we face are similar across countries and continents. It’s time to advocate for change, and defining that change is a critical first step.”

— Rachael Manion, Executive Director of the Canadian Skin Patient Alliance.

 

The global initiative is supported with funding from Leo Pharma, a Danish pharmaceutical company that operates under a private foundation owned by the LEO Foundation. Leo Pharma develops and markets products for dermatology.